Enabling CGP from Liquid Biopsy with TruSight Oncology 500 ctDNA v2
November 3, 2023
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster turn-around time from purified nucleic acid to insights and a more streamlined workflow with automation options coming in 2024! Hear more from early access users at Frederick National Laboratory. Subscribe to the Illumina video channel
youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos
youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars
youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos
youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM Facebook:
facebook.com/illuminainc LinkedIn:
linkedin.com/company/illu... Instagram:
instagram.com/illuminainc Twitter:
twitter.com/illumina #liquidbiopsy #precisionmedicine #CGP #NGS #oncology